Home NDC 69784-510-01 Humatin
Product NDC 69784-510
Requested package NDC 69784-510-01
11-digit product format 697840510
Labeler code 69784
Product ID 69784-510_8955b3e1-c1ff-436d-b450-df514a7ef04d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name PAROMOMYCIN SULFATE
Dosage form CAPSULE
Route ORAL
Labeler Woodward Pharma Services LLC
Application ANDA065173
Marketing category ANDA
Marketing start 2021-02-19
Marketing end 0000-00-00
Substance PAROMOMYCIN SULFATE
Active strength 250 mg/1
Pharmacologic classes Antiprotozoal [EPC]
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A065173-001 PAROMOMYCIN SULFATE PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL RS 2007-12-14
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL RS 2007-12-14 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL RS 2007-12-14 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL RS 2007-12-14 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL RS 2007-12-14 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL RS 2007-12-14 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL RS 2007-12-14 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL RS 2007-12-14 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL RS 2007-12-14 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL RS 2007-12-14 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL RS 2007-12-14 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL RS 2007-12-14 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL RS 2007-12-14 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL RS 2007-12-14 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL RS 2007-12-14 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL RS 2007-12-14 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL RS 2007-12-14 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL RS 2007-12-14 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A065173-001 PAROMOMYCIN SULFATE EQ 250MG BASE CAPSULE / ORAL AA 2007-12-14 cb3db0bc1861…
Observed Orange Book normalized TE history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Humatin PAROMOMYCIN SULFATE Waylis Therapeutics LLC a725f022-ec3c-430d-8021-96c861b9893c 2025-11-13 Adverse reactions Exact identifier application applno (ANDA): 065173 application number: ANDA065173
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 69784-510-01 69784051001 100 CAPSULE in 1 BOTTLE (69784-510-01) 100 capsule 2021-02-19 0000-00-00 No No Current